|
1
|
Jones AE and Puskarich MA: The surviving
sepsis campaign guidelines 2012: Update for emergency physicians.
Ann Emerg Med. 63:35–47. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hotchkiss RS and Karl IE: The
pathophysiology and treatment of sepsis. N Engl J Med. 348:138–150.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Abraham E and Singer M: Mechanisms of
sepsis-induced organ dysfunction. Crit Care Med. 35:2408–2416.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Spapen H: Liver perfusion in sepsis,
septic shock, and multiorgan failure. Anat Rec (Hoboken).
291:714–720. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Regel G, Grotz M, Weltner T, Sturm JA and
Tscherne H: Pattern of organ failure following severe trauma. World
J Surg. 20:422–429. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dhainaut JF, Marin N, Mignon A and
Vinsonneau C: Hepatic response to sepsis: Interaction between
coagulation and inflammatory processes. Crit Care Med. 29(Suppl 7):
S42–S47. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang JM and An J: Cytokines, inflammation
and pain. Int Anesthesiol Clin. 45:27–37. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schulte W, Bernhagen J and Bucala R:
Cytokines in sepsis: Potent immunoregulators and potential
therapeutic targets-an updated view. Mediators Inflamm.
2013:1659742013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Friedman G, Jankowski S, Marchant A,
Goldman M, Kahn RJ and Vincent JL: Blood interleukin 10 levels
parallel the severity of septic shock. J Crit Care. 12:183–187.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Villarino AV, Kanno Y, Ferdinand JR and
O'Shea JJ: Mechanisms of Jak/STAT signaling in immunity and
disease. J Immunol. 194:21–27. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Alexander WS: Suppressors of cytokine
signalling (SOCS) in the immune system. Nat Rev Immunol. 2:410–416.
2002.PubMed/NCBI
|
|
12
|
Yamana J, Yamamura M, Okamoto A, Aita T,
Iwahashi M, Sunahori K and Makino H: Resistance to IL-10 inhibition
of interferon gamma production and expression of suppressor of
cytokine signaling 1 in CD4+T cells from patients with rheumatoid
arthritis. Arthritis Res Ther. 6:R567–R577. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Egan PJ, Lawlor KE, Alexander WS and Wicks
IP: Suppressor of cytokine signaling-1 regulates acute inflammatory
arthritis and T cell activation. J Clin Invest. 111:915–924. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Starr R, Metcalf D, Elefanty AG, Brysha M,
Willson TA, Nicola NA, Hilton DJ and Alexander WS: Liver
degeneration and lymphoid deficiencies in mice lacking suppressor
of cytokine signaling-1. Proc Natl Acad Sci USA. 95:14395–14399.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Johnson TS, O'Leary M, Justice SK, Maamra
M, Zarkesh-Esfahani SH, Furlanetto R, Preedy VR, Hinds CJ, El Nahas
AM and Ross RJ: Differential expression of suppressors of cytokine
signalling genes in response to nutrition and growth hormone in the
septic rat. J Endocrinol. 169:409–415. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen S, Dai G, Hu J, Rong A, Lv J, Su L
and Wu X: Discovery of Xuebijing injection exhibiting protective
efficacy on sepsis by inhibiting the expression of HMGB1 in septic
rat model designed by cecal ligation and puncture. Am J Ther. Aug
25–2015.(Epub ahead of print). View Article : Google Scholar
|
|
17
|
Yin Q and Li C: Treatment effects of
Xuebijing injection in severe septic patients with disseminated
intravascular coagulation. Evid Based Complement Alternat Med.
2014:9492542014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
He XD, Wang Y, Wu Q, Wang HX, Chen ZD,
Zheng RS, Wang ZS, Wang JB and Yang Y: Xuebijing protects rats from
sepsis challenged with Acinetobacter baumannii by promoting annexin
A1 expression and inhibiting proinflammatory cytokines secretion.
Evid Based Complement Alternat Med. 2013:8049402013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu MW, Wang YH, Qian CY and Li H:
Xuebijing exerts protective effects on lung permeability leakage
and lung injury by upregulating Toll-interacting protein expression
in rats with sepsis. Int J Mol Med. 34:1492–1504. 2014.PubMed/NCBI
|
|
20
|
Rittirsch D, Huber-Lang MS, Flierl MA and
Ward PA: Immunodesign of experimental sepsis by cecal ligation and
puncture. Nat Protoc. 4:31–36. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu B, Xu P, Zhao Z, Cai J, Sternberg P and
Chen Y: Subcellular distribution and activity of mechanistic target
of rapamycin in aged retinal pigment epithelium. Invest Ophthalmol
Vis Sci. 55:8638–8650. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang Y, Dou SX, Ren H, Wang PY, Zhang XD,
Qian M, Pan BY and Xi XG: Evidence for a functional dimeric form of
the PcrA helicase in DNA unwinding. Nucleic Acids Res.
36:1976–1989. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang Y, Dou SX, Xu YN, Bazeille N, Wang
PY, Rigolet P, Xu HQ and Xi XG: Kinetic mechanism of DNA unwinding
by the BLM helicase core and molecular basis for its low
processivity. Biochemistry. 49:656–668. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Adrie C and Pinsky MR: The inflammatory
balance in human sepsis. Intensive Care Med. 26:364–375. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Koskinas J, Gomatos IP, Tiniakos DG, Memos
N, Boutsikou M, Garatzioti A, Archimandritis A and Betrosian A:
Liver histology in ICU patients dying from sepsis: A
clinico-pathological study. World J Gastroenterol. 14:1389–1393.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhu W, Bao R, Fan X, Tao T, Zhu J, Wang J,
Li J, Bo L and Deng X: PD-L1 blockade attenuated sepsis-induced
liver injury in a mouse cecal ligation and puncture model. Mediat
Inflamm. 2013:3615012013. View Article : Google Scholar
|
|
28
|
Zhang H, Wang W, Fang H, Yang Y, Li X, He
J, Jiang X, Wang W, Liu S, Hu J, et al: GSK-3β inhibition
attenuates CLP-induced liver injury by reducing inflammation and
hepatic cell apoptosis. Mediators Inflamm. 2014:6295072014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen Y, Tong H, Zhang X, Tang L, Pan Z,
Liu Z, Duan P and Su L: Xuebijing injection alleviates liver injury
by inhibiting secretory function of Kupffer cells in heat stroke
rats. J Tradit Chin Med. 33:243–249. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang Y, Ji M, Wang L, Chen L and Li J:
Xuebijing injection improves the respiratory function in rabbits
with oleic acid-induced acute lung injury by inhibiting IL-6
expression and promoting IL-10 expression at the protein and mRNA
levels. Exp Ther Med. 8:1593–1598. 2014.PubMed/NCBI
|
|
31
|
Chung CS, Chen Y, Grutkoski PS, Doughty L
and Ayala A: SOCS-1 is a central mediator of steroid-increased
thymocyte apoptosis and decreased survival following sepsis.
Apoptosis. 12:1143–1153. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Davey G, Heath W and Starr R: SOCS1: A
potent and multifaceted regulator of cytokines and cell-mediated
inflammation. Tissue Antigens. 67:1–9. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shuai K and Liu B: Regulation of JAK-STAT
signalling in the immune system. Nat Rev Immunol. 3:900–911. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fujimoto M and Naka T: Regulation of
cytokine signaling by SOCS family molecules. Trends Immunol.
24:659–666. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Guo D, Dunbar JD, Yang CH, Pfeffer LM and
Donner DB: Induction of Jak/STAT signaling by activation of the
type 1 TNF receptor. J Immunol. 160:2742–2750. 1998.PubMed/NCBI
|
|
36
|
Miscia S, Marchisio M, Grilli A, Di
Valerio V, Centurione L, Sabatino G, Garaci F, Zauli G, Bonvini E
and Di Baldassarre A: Tumor necrosis factor alpha (TNF-alpha)
activates Jak1/Stat3-Stat5B signaling through TNFR-1 in human B
cells. Cell Growth Differ. 13:13–18. 2002.PubMed/NCBI
|
